Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Publicly Available Published by De Gruyter April 11, 2023

Debate - The use of cardiac biomarkers in risk stratification

From the journal Clinical Chemistry and Laboratory Medicine (CCLM)
https://doi.org/10.1515/cclm-2023-7012
Download article (PDF)
Published Online: 2023-04-11
Published in Print: 2023-05-25

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Download article (PDF)
From the journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Clinical Chemistry and Laboratory Medicine (CCLM)
Volume 61 Issue s1
Submit manuscript

Journal and Issue

Articles in the same Issue

Frontmatter
Committees
Contents
Speakers Abstracts
Opening Lecture - Forgiveness for Individual, Family, and Community Well-Being
EFLM Symposium - Inappropriate use of laboratory resources – Demand management tools and how to use them
IFCC Symposium - Artificial intelligence applications in clinical laboratory medicine
IFCC Symposium - Precision Medicine will boost Medical Test Standardization of Protein Biomarkers
Symposium 1 - MicroRNA: from detection technologies to applications
EFLM Symposium - Precision Medicine
Sibioc Symposium - Opportunities and challenges for digital morphology in Hematology
IFCC Symposium – Central Role of the Clinical Laboratory in Public Health and Patient Care Continuum
Debate - The use of cardiac biomarkers in risk stratification
Symposium 2 - COVID-19 diagnosis, therapy and outcome
Symposium 3 - Diagnostic Challenges in Sepsis
Symposium 4 - Towards the next generation of Laboratory Information Systems
Symposium 5 - Autoimmune Diseases
IFCC Symposium - Advancing Excellence in Laboratory Medicine Worldwide: An Update from IFCC Taskforces
Sibioc - Symposium - The challenge of harmonization in laboratory medicine
EFLM Symposium - Quality in clinical laboratory: a moving target
Clinical cases – Preanalytical mysteries
Clinical cases - Bone turnover markers + vitamin D
Symposium 6 - Preanalytical phase and patient outcome
Symposium 7 - Young Scientist Session
Symposium 8 - Bone as an endocrine organ
Symposium 9 - Translating biomarkers from research to clinical use in traumatic brain injury
Sibioc Symposium - The latest advances in diabetes clinical and laboratory research
EQALM Symposium - Insights into SARS-CoV-2 associated analytics that only EQA schemes can provide
Symposium 10 - Biomarkers of liver diseases
Symposium 11 - The role of clinical laboratory in kidney transplantation
Symposium 12 - Sources of interference in laboratory testing
Symposium 13 - Prenatal testing
Sibioc Symposium - Diagnostic workup of monoclonal gammopathies
Plenary 4 - Diagnostic advances in dementia
Educational Workshops Abstracts
Educational Workshops Abstracts
Poster Abstracts
Accreditation, Quality Assurance
Analytical technologies and applications
Artificial intelligence
Atherosclerosis and lipid metabolism
Autoimmune Diseases
Cardiovascular diseases and cardiac biomarkers
COVID-19
Demand management
Dementia and neurological diseases
Diabetes, obesity, metabolic syndrome
Digital health, big data and smart technologies
Disorders of the bone metabolism and endocrine function of the bone
Endocrinology
Gastrointestinal diseases
Green laboratories
Hematology and hemostasis
Inflammation, vascular biology, endothelium, and oxidative stress
Kidney diseases and transplantation, urinanalysis
Laboratory Information Systems
Laboratory Management
MicroRNA
Miscellaneous
Molecular diagnostics
Preanalytical phase
Precision Medicine
Prenatal and neonatal testing
Sepsis
Sources of interference in laboratory testing
Traumatic brain injury
Tumor markers
Downloaded on 16.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2023-7012/html
Scroll to top button